A Hepatitis B Virus Dual Point-of-Care Test Strategy to Identify Treatment-Eligible Patients in Africa

Conference on Liver Disease in Africa (COLDA) 2023

Lifestyle Modifications - Fraja Chiwanga, MD, MMed (Int.Med), MSc

Conference on Liver Disease in Africa (COLDA) 2023

Pediatric Steatotic Liver Disease - Manal Hamdy El-Sayed, MD, PhD

Conference on Liver Disease in Africa (COLDA) 2023

A Global Action Agenda for Turning the Tide on Fatty Liver Disease - Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD

Conference on Liver Disease in Africa (COLDA) 2023

Management of Alcohol in Patients with Viral Hepatitis - Aleksander Krag, MD, PhD, MBA

Conference on Liver Disease in Africa (COLDA) 2023

Management of NASH in Patients with Viral Hepatitis - Maria Buti, MD, PhD

Conference on Liver Disease in Africa (COLDA) 2023

Role of Multidisciplinary Approach in Resource Limited Settings SOLDA Supported Session

Conference on Liver Disease in Africa (COLDA) 2023

HCC Tumor Board - Case Presentation - AASLD

Conference on Liver Disease in Africa (COLDA) 2023

Hepatocellular Carcinoma - Africa’s Experience - Ashraf Omar, MD, MSc

Conference on Liver Disease in Africa (COLDA) 2023

Platelet Count to Spleen Diameter Ratio as a Predictor of Oesophageal Varices in Patients with Liver Cirrhosis at Muhimbili National Hospital Dar es Salaam, Tanzania

Conference on Liver Disease in Africa (COLDA) 2023

Assessment of Hepatocellular Carcinoma Differences in Urban and Rural Africa Through Satellite Imaging Analysis

Conference on Liver Disease in Africa (COLDA) 2023

Implementation of HBV Screening in Kilifi, Kenya: Real World Insights to Inform Clinical Service Development and Translational Studies

Conference on Liver Disease in Africa (COLDA) 2023

Long-term Outcomes of a Population-Based Cohort of Chronic Hepatitis B (CHB) Patients in West Africa

Conference on Liver Disease in Africa (COLDA) 2023

Establishing the Hepatitis B and C Prevention and Management Program: Malawi’s Experience

Conference on Liver Disease in Africa (COLDA) 2023

Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver disease (MAFLD) Among Adults with Chronic Hepatitis B Infection in The Gambia

Conference on Liver Disease in Africa (COLDA) 2023

Fatty Liver Disease and Its Correlates Among People Living with HIV Attending Care and Treatment Clinic at Temeke Regional Referral Hospital, Dar es Salaam, Tanzania

Conference on Liver Disease in Africa (COLDA) 2023

Non-Alcoholic Fatty Liver Disease in Tanzania: Prevalence, Determinants, and Correlation with Triglycerides-Glucose Index in Overweight and Obese Individuals

Conference on Liver Disease in Africa (COLDA) 2023

Bilharzia & Viral Hepatitis - Imam Waked, MD, FRCP, FAASLD

Conference on Liver Disease in Africa (COLDA) 2023

Compared to the Wild-type, the G1862T Mutant of Hepatitis B Virus (HBV) Induces Upregulation of Fibronectin Expression and Wnt/ β--catenin Pathway in Vitro

Conference on Liver Disease in Africa (COLDA) 2023

Molecular Characterization of Hepatitis B Virus Infection in HIV Infected Adults On Antiretroviral Therapy in Nairobi, Kenya

Conference on Liver Disease in Africa (COLDA) 2023

A New Player in the Management of Liver Disease in Sub-Saharan Africa: The Tanzania IR Experience - Erick Mbuguje, MD

Conference on Liver Disease in Africa (COLDA) 2023

Management of Complications of Cirrhosis - Eva Justine Uiso, MD, MMED, MSc

Conference on Liver Disease in Africa (COLDA) 2023

Introducing Sofosbuvir/Velpatasvir+Ribavirin as a Generic Retreatment Regimen for Hepatitis C: A Prospective Cohort Study in Rwanda

Conference on Liver Disease in Africa (COLDA) 2023

Virological Characterization of Treatment Failures and Retreatment Outcomes in People Living with “Unusual” HCV Genotype 1 Subtypes

Conference on Liver Disease in Africa (COLDA) 2023